FDA warns Min­neso­ta doc for run­ning two ke­t­a­mine tri­als with­out INDs, and with chil­dren and a preg­nant woman

The FDA on Tues­day re­leased a warn­ing let­ter sent to a Min­neso­ta physi­cian who failed to ex­clude vul­ner­a­ble pop­u­la­tions from two clin­i­cal tri­als com­par­ing the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER